MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 05-30-2026
Surmodics Total Non Current Liabilities 2011-2026 | SRDX
Annual Total Non Current Liabilities Surmodics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 17.1 M | 20.4 M | 15.2 M | 15.9 M | 2.14 M | 2.07 M | 2.13 M | 2.43 M | 6.28 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.4 M | 2.07 M | 9.3 M |
Total Non Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
4.6 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
23.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
57.9 M | - | - | $ 1.31 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.17 B | $ 203.59 | -0.44 % | $ 22.6 B | USA |
 |
Celcuity
CELC
|
69.2 K | $ 88.87 | -4.02 % | $ 4.16 B | USA |
|
Akumin
AKU
|
527 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
574 K | $ 4.25 | -5.56 % | $ 5.65 M | USA |
 |
Castle Biosciences
CSTL
|
2.76 M | $ 21.19 | 0.52 % | $ 614 M | USA |
 |
Fulgent Genetics
FLGT
|
2.26 M | $ 19.02 | 2.84 % | $ 585 M | USA |
 |
Aspira Women's Health
AWH
|
3.49 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
134 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
11.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
461 M | $ 147.15 | -3.08 % | $ 11.5 B |  Irlanda |
 |
Oxford Immunotec Global PLC
OXFD
|
7.74 M | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
91.4 M | $ 130.83 | 0.55 % | $ 16.4 B | USA |
 |
Illumina
ILMN
|
2.04 B | $ 164.1 | 2.54 % | $ 25.4 B | USA |
 |
CareDx, Inc
CDNA
|
17.9 M | $ 23.71 | 4.22 % | $ 1.26 B | USA |
 |
Chembio Diagnostics
CEMI
|
24.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
10 M | $ 1.76 | 1.32 % | $ 7.79 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
4.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.53 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
131 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
161 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
37.1 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
865 K | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
225 M | $ 101.96 | 1.98 % | $ 6.88 B | USA |
 |
Charles River Laboratories International
CRL
|
2.35 B | $ 187.54 | -1.29 % | $ 9.3 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.43 B | - | - | $ 10.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
43.9 M | $ 1.4 | 1.82 % | $ 420 M | USA |
 |
Medpace Holdings
MEDP
|
73.8 M | $ 470.7 | 0.84 % | $ 13.6 B | USA |
 |
Exact Sciences Corporation
EXAS
|
981 M | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
1.61 B | $ 1 132.35 | -2.63 % | $ 23.3 B |  Schweiz |
 |
NeoGenomics
NEO
|
435 M | $ 11.47 | 0.26 % | $ 1.47 B | USA |
 |
Myriad Genetics
MYGN
|
107 M | $ 4.59 | 0.99 % | $ 425 M | USA |
 |
National Research Corporation
NRC
|
39.6 M | $ 21.0 | 6.33 % | $ 470 M | USA |
 |
Natera
NTRA
|
124 M | $ 218.38 | -1.99 % | $ 29.9 B | USA |
 |
Personalis
PSNL
|
639 K | $ 9.74 | -0.1 % | $ 869 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.45 B | $ 25.77 | -2.77 % | $ 24.4 B |  Niderland |
 |
Senseonics Holdings
SENS
|
163 M | $ 7.22 | -2.83 % | $ 301 M | USA |
 |
QIAGEN N.V.
QGEN
|
1.99 B | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
10.8 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
1.57 M | $ 2.03 | -1.02 % | $ 4.66 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
7.82 B | $ 268.15 | -1.12 % | $ 22.3 B | USA |
 |
Twist Bioscience Corporation
TWST
|
4.56 M | $ 68.37 | -2.41 % | $ 4.09 B | USA |
 |
Thermo Fisher Scientific
TMO
|
22.5 B | $ 482.91 | -2.31 % | $ 182 B | USA |
 |
Trinity Biotech plc
TRIB
|
106 M | $ 0.68 | 2.39 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
2.16 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
19.6 M | $ 9.26 | -0.32 % | $ 2.01 B | USA |
 |
Invitae Corporation
NVTA
|
320 M | - | - | $ 21.2 M | USA |